StockData
VolitionRx Ltd logo

VolitionRx Ltd (VNRX) KPIs and segments

VNRXNYSEIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 4/30
$0.19−0.01 (-5.56%)

Close on Nov 17, 2026Market cap $2.58MP/E –Yield –

KPIs & segments

Operating metrics and segments that drive VolitionRx's business

Coming soon

This tab will track the numbers specific to VolitionRx's business model — such as store count, revenue by banner, revenue per store and new openings — taken from filings and earnings releases.

See a number that looks wrong?